Suppr超能文献

慢性肝病中的骨矿物质密度与矿物质代谢紊乱

Bone mineral density and disorders of mineral metabolism in chronic liver disease.

作者信息

George Joe, Ganesh Hosahithlu K, Acharya Shrikrishna, Bandgar Tushar R, Shivane Vyankatesh, Karvat Anjana, Bhatia Shobna J, Shah Samir, Menon Padmavathy S, Shah Nalini

机构信息

Department of Endocrinology, KEM Hospital, Parel, Mumbai 400012, India.

出版信息

World J Gastroenterol. 2009 Jul 28;15(28):3516-22. doi: 10.3748/wjg.15.3516.

Abstract

AIM

To estimate the prevalence and identify the risk factors for metabolic bone disease in patients with cirrhosis.

METHODS

The study was performed on 72 Indian patients with cirrhosis (63 male, nine female; aged < 50 years). Etiology of cirrhosis was alcoholism (n = 37), hepatitis B (n = 25) and hepatitis C (n = 10). Twenty-three patients belonged to Child class A, while 39 were in class B and 10 in class C. Secondary causes for metabolic bone disease and osteoporosis were ruled out. Sunlight exposure, physical activity and dietary constituents were calculated. Complete metabolic profiles were derived, and bone mineral density (BMD) was measured using dual energy X ray absorptiometry. Low BMD was defined as a Z score below -2.

RESULTS

Low BMD was found in 68% of patients. Lumbar spine was the most frequently and severely affected site. Risk factors for low BMD included low physical activity, decreased sunlight exposure, and low lean body mass. Calcium intake was adequate, with unfavorable calcium: protein ratio and calcium: phosphorus ratio. Vitamin D deficiency was highly prevalent (92%). There was a high incidence of hypogonadism (41%). Serum estradiol level was elevated significantly in patients with normal BMD. Insulin-like growth factor (IGF) 1 and IGF binding protein 3 levels were below the age-related normal range in both groups. IGF-1 was significantly lower in patients with low BMD. Serum osteocalcin level was low (68%) and urinary deoxypyridinoline to creatinine ratio was high (79%), which demonstrated low bone formation with high resorption.

CONCLUSION

Patients with cirrhosis have low BMD. Contributory factors are reduced physical activity, low lean body mass, vitamin D deficiency and hypogonadism and low IGF-1 level.

摘要

目的

评估肝硬化患者代谢性骨病的患病率并确定其危险因素。

方法

对72例印度肝硬化患者(63例男性,9例女性;年龄<50岁)进行了研究。肝硬化的病因包括酒精中毒(n = 37)、乙型肝炎(n = 25)和丙型肝炎(n = 10)。23例患者属于Child A级,39例属于B级,10例属于C级。排除代谢性骨病和骨质疏松症的继发原因。计算阳光暴露、体力活动和饮食成分。得出完整的代谢谱,并使用双能X线吸收法测量骨密度(BMD)。低骨密度定义为Z值低于-2。

结果

68%的患者存在低骨密度。腰椎是最常且最严重受影响的部位。低骨密度的危险因素包括体力活动少、阳光暴露减少和瘦体重低。钙摄入量充足,但钙与蛋白质的比例以及钙与磷的比例不理想。维生素D缺乏非常普遍(92%)。性腺功能减退的发生率很高(41%)。骨密度正常的患者血清雌二醇水平显著升高。两组患者的胰岛素样生长因子(IGF)1和IGF结合蛋白3水平均低于年龄相关的正常范围。低骨密度患者的IGF-1显著更低。血清骨钙素水平低(68%),尿脱氧吡啶啉与肌酐比值高(79%),这表明骨形成低而骨吸收高。

结论

肝硬化患者存在低骨密度。促成因素包括体力活动减少、瘦体重低、维生素D缺乏、性腺功能减退和IGF-1水平低。

相似文献

1
Bone mineral density and disorders of mineral metabolism in chronic liver disease.
World J Gastroenterol. 2009 Jul 28;15(28):3516-22. doi: 10.3748/wjg.15.3516.
5
Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
J Endocrinol Invest. 2000 May;23(5):295-303. doi: 10.1007/BF03343726.

引用本文的文献

1
Liver function linked to bone health: A bibliometric of the liver-bone axis.
World J Hepatol. 2025 Feb 27;17(2):103016. doi: 10.4254/wjh.v17.i2.103016.
2
Environmental Cadmium Exposure Exacerbated Bone Loss in NAFLD Mice.
Biol Trace Elem Res. 2024 Oct;202(10):4586-4595. doi: 10.1007/s12011-023-04016-0. Epub 2023 Dec 15.
3
Vitamin D status & bone health in patients with liver cirrhosis.
Indian J Med Res. 2023 Sep;158(3):284-291. doi: 10.4103/ijmr.IJMR_1144_20.
4
Bone loss in chronic liver diseases: Could healthy liver be a requirement for good bone health?
World J Gastroenterol. 2023 Feb 7;29(5):825-833. doi: 10.3748/wjg.v29.i5.825.
6
Common musculoskeletal disorders in chronic liver disease patients.
Jt Dis Relat Surg. 2021;32(3):818-823. doi: 10.52312/jdrs.2021.25. Epub 2021 Nov 19.
8
Association between osteoporosis and hepatitis B cirrhosis: a case-control study.
Afr Health Sci. 2020 Dec;20(4):1610-1616. doi: 10.4314/ahs.v20i4.13.
9
Determining Bone Turnover Status in Patients With Chronic Liver Disease.
Cureus. 2021 Apr 13;13(4):e14479. doi: 10.7759/cureus.14479.

本文引用的文献

1
Evaluation and management of osteoporosis in liver disease.
Clin Liver Dis. 2005 Nov;9(4):747-66, viii. doi: 10.1016/j.cld.2005.07.003.
2
AGA technical review on osteoporosis in hepatic disorders.
Gastroenterology. 2003 Sep;125(3):941-66. doi: 10.1016/s0016-5085(03)01062-x.
3
Osteoporosis in liver diseases and after liver transplantation.
J Hepatol. 2003 Jun;38(6):856-65. doi: 10.1016/s0168-8278(03)00143-0.
4
Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption.
J Clin Endocrinol Metab. 2002 Nov;87(11):4952-6. doi: 10.1210/jc.2002-020636.
5
Clinical review 144: Estrogen and the male skeleton.
J Clin Endocrinol Metab. 2002 Apr;87(4):1443-50. doi: 10.1210/jcem.87.4.8417.
6
Guidelines on the management of osteoporosis associated with chronic liver disease.
Gut. 2002 Feb;50 Suppl 1(Suppl 1):i1-9. doi: 10.1136/gut.50.suppl_1.i1.
7
Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis.
Dig Dis Sci. 2000 Jul;45(7):1392-9. doi: 10.1023/a:1005568406664.
9
Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment.
J Hepatol. 1998 Jan;28(1):122-31. doi: 10.1016/s0168-8278(98)80211-0.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验